TALPHERA, INC.

Profile

Company Names

TALPHERA, INC.
ACELRX PHARMACEUTICALS INC

Addresses

1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA 94404

25821 INDUSTRIAL BOULEVARD, SUITE 400, HAYWARD, CA 94545

25821 INDUSTRIAL BOULEVARD, SUITE 400, HAYWARD, CA 94545

351 GALVESTON DRIVE, REDWOOD CITY, CA 94063

575 CHESAPEAKE DRIVE, REDWOOD CITY, CA 94063

Phone Numbers

650-216-3500

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$97,350,864.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2025-09-10 
$16,984,999.00 
$28,969,997.00 
$11,984,998.00 
Equity 
9
2025-04-02 
$4,920,000.00 
$15,000,000.00 
$10,080,000.00 
Equity 
8
2024-01-22 
$6,000,000.00 
$6,000,000.00 
$0.00 
 
7
2023-07-17 
$10,000,008.00 
$10,000,008.00 
$0.00 
Equity 
6
2022-08-03 
$629,958.00 
$629,958.00 
$0.00 
Equity 
5
2022-01-07 
$5,160,997.00 
$5,960,979.00 
$799,982.00 
Equity 
4
2012-06-01 
$10,000,002.00 
$10,000,002.00 
$0.00 
Equity 
3
2011-06-29 
$20,839,994.00 
$20,839,994.00 
$0.00 
Debt 
2
2010-09-14 
$8,000,800.00 
$12,001,200.00 
$4,000,400.00 
Debt 
1
2009-11-23 
$14,814,106.00 
$30,000,000.00 
$15,185,894.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICHARD 
 
AFABLE 
DIRECTOR
VINCENT 
 
ANGOTTI 
EXECUTIVE OFFICER, DIRECTOR
VINCENT 
ANGOTTI 
EXECUTIVE OFFICER, DIRECTOR
VINCENT 
J. 
ANGOTTI 
EXECUTIVE OFFICER, DIRECTOR
RAFFI 
 
ASADORIAN 
EXECUTIVE OFFICER
SHAKIL 
 
ASLAM 
EXECUTIVE OFFICER
MARINA 
 
BOZILENKO 
DIRECTOR
ANIL 
 
DASU 
EXECUTIVE OFFICER
BADRI 
 
DASU 
EXECUTIVE OFFICER
BADRI 
N. 
DASU 
EXECUTIVE OFFICER
BADRI 
DASU 
EXECUTIVE OFFICER
LARRY 
 
HAMEL 
EXECUTIVE OFFICER
STEPHEN 
HOFFMAN 
DIRECTOR
STEPHEN 
J. 
HOFFMAN 
DIRECTOR
ABHINAV 
 
JAIN 
DIRECTOR
LINDA 
 
JUDGE 
EXECUTIVE OFFICER
CARTER 
 
KING 
EXECUTIVE OFFICER
RICHARD 
 
KING 
EXECUTIVE OFFICER, DIRECTOR
HAMEL 
G. 
LAWRENCE 
EXECUTIVE OFFICER
PAMELA 
 
PALMER 
EXECUTIVE OFFICER, DIRECTOR
PAMELA 
PALMER 
EXECUTIVE OFFICER, DIRECTOR
PAMELA 
P. 
PALMER 
EXECUTIVE OFFICER, DIRECTOR
HOWARD 
ROSEN 
DIRECTOR
HOWARD 
B. 
ROSEN 
DIRECTOR
HOWIE 
 
ROSEN 
DIRECTOR
THOMAS 
 
SCHRECK 
DIRECTOR
THOMAS 
SCHRECK 
EXECUTIVE OFFICER, DIRECTOR
STEVE 
 
SULLIVAN 
DIRECTOR
MARK 
WEEKS 
EXECUTIVE OFFICER
JAMES 
 
WELCH 
EXECUTIVE OFFICER
JAMES 
H. 
WELCH 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-09-10 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-04-02 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2024-01-22 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-07-17 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-01-07 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-06-01 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2011-06-29 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-09-14 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-11-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
BTIG, LLC
NONE
NONE
A.G.P./ALLIANCE GLOBAL PARTNERS
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375